Literature DB >> 10809465

Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.

K Roth1, J Lynn, Z Zhong, M Borum, N V Dawson.   

Abstract

OBJECTIVES: To understand patterns of care and end-of-life preferences for patients dying with end stage liver disease with cirrhosis (ESLDC).
METHODS: Data were collected during the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment (SUPPORT), a prospective cohort study of seriously ill hospitalized adults at five teaching hospitals in the United States, and included all patients enrolled in SUPPORT with ESLDC.
RESULTS: Of 575 patients with ESLDC, 166 died during index hospitalization, and 168 died in the following year. The majority were male (65%) and white (80%); the median age was 52 years. Most rated their quality of life as poor or fair, and multiple comorbidities were common. Most spent their last few days completely disabled. Families often reported loss of most income and the need to leave work or other activities in order to care for patients. Pain was at least moderately severe most of the time in one-third of patients. End-of-life preferences were not associated with survival. Most patients (66.8%) preferred CPR, but DNR orders and orders against ventilator use increased near death.
CONCLUSIONS: Patients with liver disease were young, likely to be male, and often had low incomes. The high burden of pain was comparable to that reported for patients with lung and colon cancer. Persons dying with liver disease may benefit from increased attention to relief of symptoms, improved home care, and advanced care planning.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT)

Mesh:

Year:  2000        PMID: 10809465

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  38 in total

Review 1.  Integration of palliative care in end-stage liver disease and liver transplantation.

Authors:  Jamie Potosek; Michael Curry; Mary Buss; Eva Chittenden
Journal:  J Palliat Med       Date:  2014-11       Impact factor: 2.947

2.  Physicians' Perspectives on Palliative Care for Patients With End-Stage Liver Disease: A National Survey Study.

Authors:  Nneka N Ufere; John Donlan; Lauren Waldman; Arpan Patel; Jules L Dienstag; Lawrence S Friedman; Kathleen E Corey; Nikroo Hashemi; Peter Carolan; Alan C Mullen; Michael Thiim; Irun Bhan; Ryan Nipp; Joseph Greer; Jennifer Temel; Raymond T Chung; Areej El-Jawahri
Journal:  Liver Transpl       Date:  2019-05-03       Impact factor: 5.799

3.  Research priorities in geriatric palliative care: an introduction to a new series.

Authors:  R Sean Morrison
Journal:  J Palliat Med       Date:  2013-05-30       Impact factor: 2.947

4.  Symptom distress in patients with end-stage liver disease toward the end of life.

Authors:  Lissi Hansen; Michael C Leo; Michael F Chang; Atif Zaman; Willscott Naugler; Jonathan Schwartz
Journal:  Gastroenterol Nurs       Date:  2015 May-Jun       Impact factor: 0.978

Review 5.  Palliative care for patients with end-stage liver disease.

Authors:  Anne M Larson
Journal:  Curr Gastroenterol Rep       Date:  2015-05

6.  Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention.

Authors:  Benjamin E Hudson; Kelly Ameneshoa; Anya Gopfert; Rachael Goddard; Karen Forbes; Julia Verne; Peter Collins; Fiona Gordon; Andrew J Portal; Colette Reid; C Anne McCune
Journal:  Frontline Gastroenterol       Date:  2016-10-05

7.  The treatment of hepatic encephalopathy in the cirrhotic patient.

Authors:  Arun J Sanyal; Kevin D Mullen; Nathan M Bass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

8.  Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients.

Authors:  Alastair J O'Brien; Cathy A Welch; Mervyn Singer; David A Harrison
Journal:  Intensive Care Med       Date:  2012-03-29       Impact factor: 17.440

9.  Palliative Care and Hospice Referrals in Patients with Decompensated Cirrhosis: What Factors Are Important?

Authors:  John H Holden; Hani Shamseddeen; Amy W Johnson; Benjamin Byriel; Kavitha Subramoney; Yao-Wen Cheng; Akira Saito; Marwan Ghabril; Naga Chalasani; Greg A Sachs; Eric S Orman
Journal:  J Palliat Med       Date:  2020-02-24       Impact factor: 2.947

10.  Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease.

Authors:  C D Wells; W B Murrill; M R Arguedas
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.